首页> 外国专利> Controlled release solid drug composition obtained by thermoforming

Controlled release solid drug composition obtained by thermoforming

机译:通过热成型获得的控释固体药物组合物

摘要

Controlled release solid pharmaceutical compositions containing an active material and one or more polymethacrylates. The compositions are prepared by thermoforming a mixture of the active material and the polymethacrylate(s), the release properties being determined by the nature of the polymethacrylate(s), their relative amounts, and the technique used to make the compositions. Preferably the polymethacrylate(s) are Eudragit (RTM) RL and/or RS, optionally with Eudragit E. The ingredients are mixed and then thermoformed at 60 - 150 degrees C, preferably 80 - 130 degrees C by an extrusion or injection process. The use of a co-extrusion or co-injection procedure, in which the inner and outer layers have different compositions is particularly preferred. Additional components that may be incorporated include antioxidants, flavors, colors, preservatives, sweeteners, and anti-adherents.
机译:含有活性物质和一种或多种聚甲基丙烯酸酯的控释固体药物组合物。通过热成型活性材料和聚甲基丙烯酸酯的混合物来制备组合物,其释放性能取决于聚甲基丙烯酸酯的性质,它们的相对量以及用于制备该组合物的技术。优选地,一种或多种聚甲基丙烯酸酯是Eudragit(RTM)RL和/或RS,任选地与Eudragit E一起。将成分混合,然后通过挤出或注射方法在60-150℃,优选80-130℃下热成型。特别优选使用共挤出或共注射程序,其中内层和外层具有不同的组成。可以加入的其他成分包括抗氧化剂,调味剂,色素,防腐剂,甜味剂和抗粘剂。

著录项

  • 公开/公告号DK1064935T3

    专利类型

  • 公开/公告日2008-08-25

    原文格式PDF

  • 申请/专利权人 LES LABORATOIRES SERVIER;

    申请/专利号DK20000401825T

  • 申请日2000-06-27

  • 分类号A61K9/20;A61K31/745;A61K9;A61K9/22;A61K9/32;A61K31/16;A61K31/325;A61K31/381;A61K31/382;A61K31/403;A61K31/404;A61K31/421;A61K31/438;A61K31/506;A61K31/542;A61K31/69;A61K47/32;A61P3/10;A61P9/12;

  • 国家 DK

  • 入库时间 2022-08-21 20:08:26

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号